“Pharmacokinetics and potency of progestins used for hormone replacement therapy and contraception”. Reviews in Endocrine & Metabolic Disorders3 (3): 211–224. (September 2002). doi:10.1023/A:1020072325818. PMID12215716.
“The absorption of oral micronized progesterone: the effect of food, dose proportionality, and comparison with intramuscular progesterone”. Fertility and Sterility60 (1): 26–33. (July 1993). doi:10.1016/S0015-0282(16)56031-2. PMID8513955.
“Progesterone and testosterone hydroxylation by cytochromes P450 2C19, 2C9, and 3A4 in human liver microsomes”. Archives of Biochemistry and Biophysics346 (1): 161–169. (October 1997). doi:10.1006/abbi.1997.0302. PMID9328296.
“Pharmaceutical and clinical development of a novel progesterone formulation”. Acta Obstetricia et Gynecologica Scandinavica94 (Suppl 161): 28–37. (November 2015). doi:10.1111/aogs.12765. PMID26342177.
“Pharmacokinetics and potency of progestins used for hormone replacement therapy and contraception”. Reviews in Endocrine & Metabolic Disorders3 (3): 211–224. (September 2002). doi:10.1023/A:1020072325818. PMID12215716.
“The absorption of oral micronized progesterone: the effect of food, dose proportionality, and comparison with intramuscular progesterone”. Fertility and Sterility60 (1): 26–33. (July 1993). doi:10.1016/S0015-0282(16)56031-2. PMID8513955.
“Progesterone and testosterone hydroxylation by cytochromes P450 2C19, 2C9, and 3A4 in human liver microsomes”. Archives of Biochemistry and Biophysics346 (1): 161–169. (October 1997). doi:10.1006/abbi.1997.0302. PMID9328296.
“Pharmaceutical and clinical development of a novel progesterone formulation”. Acta Obstetricia et Gynecologica Scandinavica94 (Suppl 161): 28–37. (November 2015). doi:10.1111/aogs.12765. PMID26342177.